HCA Healthcare (HCA) official guidance

Medicaid supplemental payment programs net benefit between $300 million and $500 million.

| Medicaid Supplemental Payment Programs | ($50) to ($250) million | $300 to $500 million |

| Medicaid Supplemental Payment Programs | ($50) to ($250) million | $300 to $500 million |

| Depreciation and amortization | | 3,745 | | 3,795 |

| Depreciation and amortization | | 3,745 | | 3,795 |

| Depreciation and amortization | | 3,705 | | 3,775 |

| Depreciation and amortization | | 3,705 | | 3,775 |

| Shares used in computing diluted earnings per share (millions) | | 219.500 | | 219.500 |

| Shares used in computing diluted earnings per share (millions) | | 219.500 | | 219.500 |

| Shares used in computing diluted earnings per share (millions) | | 223.500 | | 223.500 |

| Shares used in computing diluted earnings per share (millions) | | 223.500 | | 223.500 |

Adjusted EBITDA between $15.4 billion and $16.1 billion.

| Adjusted EBITDA (a) (b) | $ | 15,400 | | 16,100 |

| Adjusted EBITDA (a) (b) | $ | 15,400 | | $ | 16,100 |

| Adjusted EBITDA (a) (b) | $ | 15,550 | | $ | 16,450 |

We expect Adjusted EBITDA to range between $15.55 billion and $16.45 billion.

| Adjusted EBITDA | $15.550 to $16.450 billion | |

Diluted earnings per share between $28.70 and $30.50.

| Net income attributable to HCA Healthcare, Inc. | $ | 28.70 | $ | 30.50 |

| Net income attributable to HCA Healthcare, Inc. | $ | 28.70 | | $ | 30.50 |

| Diluted earnings per share: | | | | | | | | Net income attributable to HCA Healthcare, Inc. | $ | 29.10 | $ | 31.50 |

We expect diluted earnings per share to range between $29.10 and $31.50.

| EPS (diluted) | $29.10 to $31.50 per diluted share | |

| Provision for income taxes | | 1,975 | | 2,125 |

| Provision for income taxes | | 1,975 | | 2,125 |

| Provision for income taxes | | 2,010 | | 2,160 |

| Provision for income taxes | | 2,010 | | 2,160 |

| Interest expense | | 2,410 | | 2,470 |

| Interest expense | | 2,410 | | 2,470 |

| Interest expense | | 2,330 | | 2,420 |

| Interest expense | | 2,330 | | 2,420 |

Net income attributable to HCA Healthcare between $6.3 billion and $6.7 billion.

| Net income attributable to HCA Healthcare, Inc. (a) | $ | 6,300 | $ | 6,700 |

| Net income attributable to HCA Healthcare, Inc. (a) | $ | 6,300 | | $ | 6,700 |

| Net income attributable to HCA Healthcare, Inc. (a) | $ | 6,495 | $ | 7,035 |

We expect net income attributable to HCA Healthcare to range between $6.5 billion and $7 billion.

| Net Income Attributable to HCA Healthcare, Inc. | $6.495 to $7.035 billion | |

| Net income attributable to noncontrolling interests | | 970 | | 1,010 |

| Net income attributable to noncontrolling interests | | 970 | | 1,010 |

| Net income attributable to noncontrolling interests | | 1,010 | | 1,060 |

| Net income attributable to noncontrolling interests | | 1,010 | | 1,060 |

Revenue between $77 billion and $79.5 billion.

| Revenues | $ | 77,000 | $ | 79,500 |

| Revenues | $ | 77,000 | $ | 79,500 |

| Revenues | $ | 76,500 | $ | 80,000 |

We expect revenues to range between $76.5 billion and $80 billion.

| Revenues | $76.500 to $80.000 billion | |

The Company's 2026 estimate for capital expenditures of $5.0 billion to $5.5 billion, excluding acquisitions, remains unchanged.

The Company's 2026 estimate for capital expenditures of $5.0 billion to $5.5 billion, excluding acquisitions, remains unchanged.

As a result of these opportunities, we have increased our capital spending range from $5 billion to $5.5 billion.

Capital expenditures for 2026, excluding acquisitions, are estimated to range between $5.0 billion and $5.5 billion.

| Health Insurance Exchanges | ($600) to ($900) million | ($1.000) to ($1.200) billion |